How to Keep an Aging Dog Comfortable at Home

Posted on June 5th, 2019 by VetDC

At VetDC, we often come across helpful articles that have relevance not only for dogs with lymphoma and other cancers, but also for any dog that might be ailing or simply showing signs of old age. The needs of your … Keep Reading

Elanco Announces Agreements with Aratana Therapeutics and VetDC, Creates Specialty Veterinary Business Focus

Posted on April 26th, 2019 by VetDC

Elanco Animal Health (NYSE: ELAN) today announced it has signed an agreement to acquire Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID … Keep Reading

TANOVEA-CA1 Canine Lymphoma Treatment Delivers Excellent Results for Stella

Posted on December 18th, 2018 by VetDC

Earlier this year, the team at NorthStar VETS in New Jersey shared the story of Stella in a guest post to the VetDC blog. Stella had been diagnosed with canine lymphoma in March 2017. She nearly completed two cycles … Keep Reading

Reason for Hope as We Observe National Canine Lymphoma Awareness Day

Posted on November 7th, 2018 by VetDC

National Canine Lymphoma Awareness Day is observed each year on November 7 to help draw attention to the prevalence of this deadly disease and the advances being made in treating it. Highly regarded dog agility trainer Terry Simons founded an … Keep Reading

GUEST POST: NorthStar VETS Uses TANOVEA-CA1 for Canine Lymphoma Patients

Posted on May 10th, 2018 by VetDC

NorthStar VETS, New Jersey – NorthStar VETS recently began using TANOVEA-CA1 in the treatment of 8-year-old Stella. Stella was diagnosed with lymphoma in March 2017. She nearly completed two cycles of CHOP chemotherapy when her disease progressed. In April 2018 … Keep Reading

Have You Considered Pet Insurance? A Brief Overview.

Posted on February 27th, 2018 by VetDC

As veterinary medicine advances with breakthroughs like TANOVEA™-CA1 (rabacfosadine for injection) cancer treatment for dogs, our pets have the opportunity to live longer, healthier lives. However, even as pet owners celebrate that fact, they have to consider the cost of … Keep Reading

(Video) VCS Interview with Dr. Andrew Novosad

Posted on December 15th, 2017 by VetDC

Dr. Sue Cancer Vet posted an oncologist interview with Dr. Andrew Novosad as part of her VCS interview series. Novosad described TANOVEA-CA1 (rabacfosadine for injection) as the most significant highlight of this year’s VCS Conference and shared why he is so … Keep Reading

VetDC Announces New TANOVEA®-CA1 Publication, State of the Art Presentation at VCS 2017 Annual Conference

Posted on November 3rd, 2017 by VetDC

FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State … Keep Reading

TANOVEA-CA1 Noted in Veterinary Brief Article

Posted on October 25th, 2017 by VetDC

As Sue Ettinger, DVM, DACVIM (Oncology), of Tarrytown, New York, explains in a new article on the Veterinary Brief website, canine lymphoma, one of the most common canine cancers, is actually a collection of cancers arising from the malignant transformation … Keep Reading

VetDC/CSU Partnership Highlighted in Article on Research Spending

Posted on October 11th, 2017 by VetDC

TANOVEA®-CA1 (rabacfosadine for injection), a novel treatment for lymphoma in dogs, is the result of a powerful collaboration involving VetDC, veterinarians nationwide, and the families that allow us to care for their dogs with lymphoma. VetDC was originally founded out … Keep Reading